In this report, according to this study, over the next five years the Antibody-drug Conjugatesmarket will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026, from US$ xx million in 2020. In particular, this report presents the global market share (sales and revenue) of key companies in Antibody-drug Conjugatesbusiness.
Antibody-drug Conjugates market development trend, sales volume and sales value (million USD) forecast in regional market, the main regions are China, USA, Europe, India, Japan, Korea, South America, Southeast Asia.
Sales forecast by type/application from 2021-2026
Industry chain, downstream and upstream information is also included.
Geographically, this report split global into several key Regions, with sales (K Units), revenue (M USD), market share and growth rate of Antibody-drug Conjugates for these regions, from 2014 to 2026 (forecast), covering
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America
Global Antibody-drug Conjugates market competition by top manufacturers/players, with Antibody-drug Conjugates sales volume, Price (USD/Unit), revenue (M USD) and market share for each manufacturer/player; the top players including
ImmunoGen
Seattle Genetics
Roche
Takeda
...
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Adcetris
Kadcyla
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Antibody-drug Conjugates for each application, including
Breast Cancer
Lymphoma
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
1 Executive Summary
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Antibody-drug Conjugates Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Analysis by Types
2.1 Overall Market Performance(Volume)
2.1.1 Adcetris
2.1.2 Kadcyla
2.2 Overall Market Performance(Value)
2.2.1 Adcetris
2.2.2 Kadcyla
3 Product Application Market
3.1 Overall Market Performance (Volume)
3.1.1 Breast Cancer
3.1.2 Lymphoma
4 Manufacturers Profiles/Analysis
4.1 ImmunoGen
4.1.1 ImmunoGen Profiles
4.1.2 ImmunoGen Product Information
4.1.3 ImmunoGen Antibody-drug Conjugates Sales, Sales Value(Million USD), Price and Gross Profit
4.1.4 ImmunoGen SWOT Analysis
4.2 Seattle Genetics
4.2.1 Seattle Genetics Profiles
4.2.2 Seattle Genetics Product Information
4.2.3 Seattle Genetics Antibody-drug ConjugatesSales, Sales Value (Million USD), Price and Gross Profit
4.2.4 Seattle Genetics SWOT Analysis
4.3 Roche
4.3.1 Roche Profiles
4.3.2 Roche Product Information
4.3.3 Roche Antibody-drug ConjugatesSales, Sales Value (Million USD), Price and Gross Profit
4.3.4 Roche SWOT Analysis
4.4 Takeda
4.4.1 Takeda Profiles
4.4.2 Takeda Product Information
4.4.3 Takeda Antibody-drug ConjugatesSales, Sales Value (Million USD), Price and Gross Profit
4.4.4 Takeda SWOT Analysis
5 Market Performance for Manufacturers
5.1 Global Antibody-drug Conjugates Sales (K Units) and Market Share by Manufacturers 2014-2020
5.2 Global Antibody-drug Conjugates Revenue (M USD) and Market Share by Manufacturers 2014-2020
5.3 Global Antibody-drug Conjugates Price (USD/Unit) of Manufacturers 2014-2020
5.4 Global Antibody-drug Conjugates Gross Margin of Manufacturers 2014-2020
5.5 Market Concentration
6 Regions Market Performance for Manufacturers
6.1 China Market Performance for Manufacturers
6.1.1 China Antibody-drug Conjugates Sales (K Units) and Share of Manufacturers 2014-2020
6.1.2 China Antibody-drug Conjugates Revenue (M USD) and Share of Manufacturers 2014-2020
6.1.3 China Antibody-drug Conjugates Price (USD/Unit) of Manufacturers 2014-2020
6.1.4 China Antibody-drug Conjugates Gross Margin of Manufacturers 2014-2020
6.1.5 Market Concentration
6.2 USA Market Performance for Manufacturers
6.2.1 USA Antibody-drug Conjugates Sales (K Units) and Share of Manufacturers 2014-2020
6.2.2 USA Antibody-drug Conjugates Revenue (M USD) and Share of Manufacturers 2014-2020
6.2.3 USA Antibody-drug Conjugates Price (USD/Unit) of Manufacturers 2014-2020
6.2.4 USA Antibody-drug Conjugates Gross Margin of Manufacturers 2014-2020
6.2.5 Market Concentration
6.3 Europe Market Performance for Manufacturers
6.3.1 Europe Antibody-drug Conjugates Sales (K Units) and Share of Manufacturers 2014-2020
6.3.2 Europe Antibody-drug Conjugates Revenue (M USD) and Share of Manufacturers 2014-2020
6.3.3 Europe Antibody-drug Conjugates Price (USD/Unit) of Manufacturers 2014-2020
6.3.4 Europe Antibody-drug Conjugates Gross Margin of Manufacturers 2014-2020
6.3.5 Market Concentration
6.4 Japan Market Performance for Manufacturers
6.4.1 Japan Antibody-drug Conjugates Sales (K Units) and Share of Manufacturers 2014-2020
6.4.2 Japan Antibody-drug Conjugates Revenue (M USD) and Share of Manufacturers 2014-2020
6.4.3 Japan Antibody-drug Conjugates Price (USD/Unit) of Manufacturers 2014-2020
6.4.4 Japan Antibody-drug Conjugates Gross Margin of Manufacturers 2014-2020
6.4.5 Market Concentration
6.5 Korea Market Performance for Manufacturers
6.5.1 Korea Antibody-drug Conjugates Sales (K Units) and Share of Manufacturers 2014-2020
6.5.2 Korea Antibody-drug Conjugates Revenue (M USD) and Share of Manufacturers 2014-2020
6.5.3 Korea Antibody-drug Conjugates Price (USD/Unit) of Manufacturers 2014-2020
6.5.4 Korea Antibody-drug Conjugates Gross Margin of Manufacturers 2014-2020
6.5.5 Market Concentration
6.6 India Market Performance for Manufacturers
6.6.1 India Antibody-drug Conjugates Sales (K Units) and Share of Manufacturers 2014-2020
6.6.2 India Antibody-drug Conjugates Revenue (M USD) and Share of Manufacturers 2014-2020
6.6.3 India Antibody-drug Conjugates Price (USD/Unit) of Manufacturers 2014-2020
6.6.4 India Antibody-drug Conjugates Gross Margin of Manufacturers 2014-2020
6.6.5 Market Concentration
6.7 Southeast Asia Market Performance for Manufacturers
6.7.1 Southeast Asia Antibody-drug Conjugates Sales (K Units) and Share of Manufacturers 2014-2020
6.7.2 Southeast Asia Antibody-drug Conjugates Revenue (M USD) and Share of Manufacturers 2014-2020
6.7.3 Southeast Asia Antibody-drug Conjugates Price (USD/Unit) of Manufacturers 2014-2020
6.7.4 Southeast Asia Antibody-drug Conjugates Gross Margin of Manufacturers 2014-2020
6.7.5 Market Concentration
6.8 South America Market Performance for Manufacturers
6.8.1 South America Antibody-drug Conjugates Sales (K Units) and Share of Manufacturers 2014-2020
6.8.2 South America Antibody-drug Conjugates Revenue (M USD) and Share of Manufacturers 2014-2020
6.8.3 South America Antibody-drug Conjugates Price (USD/Unit) of Manufacturers 2014-2020
6.8.4 South America Antibody-drug Conjugates Gross Margin of Manufacturers 2014-2020
6.8.5 Market Concentration
7 Global Antibody-drug Conjugates Market Assessment by Regions (2014-2020)
7.1 Global Antibody-drug Conjugates Sales (K Units) and Market Share by Regions 2014-2020
7.2 Global Antibody-drug Conjugates Revenue (M USD) and Market Share by Regions 2014-2020
7.3 Global Antibody-drug Conjugates Price (USD/Unit) by Regions 2014-2020
7.4 Global Antibody-drug Conjugates Gross Margin by Regions 2014-2020
8 Development Trend for Regions
8.1 Global Antibody-drug Conjugates Sales and Growth, Sales Value and Growth Rate 2014-2020
8.2 China Antibody-drug Conjugates Sales and Growth, Sales Value and Growth Rate 2014-2020
8.3 USA Antibody-drug Conjugates Sales and Growth, Sales Value and Growth Rate2014-2020
8.4 Europe Antibody-drug Conjugates Sales and Growth, Sales Value and Growth Rate 2014-2020
8.5 Japan Antibody-drug Conjugates Sales and Growth, Sales Value and Growth Rate 2014-2020
8.6 Korea Antibody-drug Conjugates Sales and Growth, Sales Value and Growth Rate 2014-2020
8.7 India Antibody-drug Conjugates Sales and Growth, Sales Value and Growth Rate 2014-2020
8.8 Southeast Asia Antibody-drug Conjugates Sales and Growth, Sales Value and Growth Rate 2014-2020
8.8 Southeast Asia Antibody-drug Conjugates Sales and Growth, Sales Value and Growth Rate 2014-2020
9 Upstream Source, Technology and Cost
9.1 Upstream Source
9.2 Technology
9.3 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Manufacturing Plants Distribution
11 Consumer Analysis
11.1 Breast Cancer Industry
11.2 Lymphoma Industry
12 Market Forecast 2021-2026
12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
12.1.1 Global Antibody-drug Conjugates Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
12.1.2 Global Antibody-drug Conjugates Sales (K Units) and Growth Rate 2021-2026
12.1.3 China Antibody-drug Conjugates Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.4 USA Antibody-drug Conjugates Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.5 Europe Antibody-drug Conjugates Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.6 Japan Antibody-drug Conjugates Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.7 Korea Antibody-drug Conjugates Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.8 India Antibody-drug Conjugates Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.9 Southeast Asia Antibody-drug Conjugates Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.10 South America Antibody-drug Conjugates Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2 Sales (K Units), Revenue (M USD) Forecast by Types 2021-2026
12.2.1 Overall Market Performance
12.2.2 Adcetris
12.2.3 Kadcyla
12.3 Sales (K Units) Forecast by Application 2021-2026
12.3.1 Overall Market Performance
12.3.2 Breast Cancer
12.3.3 Lymphoma
12.4 Price (USD/Unit) and Gross Profit
12.4.1 Global Antibody-drug Conjugates Price (USD/Unit) Trend 2021-2026
12.4.2 Global Antibody-drug Conjugates Gross Profit Trend 2021-2026
13 Conclusion
The Drug Temperature Monitoring System Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ...
The Small Molecule Drug CDMO Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, m...
Executive Summary
Azoth Analytics has released a research report titled "Global Immune Thrombocytopenia Drug Market (2024 Edition)" which provides a complete analysis of the Global Immune Thrombocytopenia Drug industry in terms of market segmentation By Treatment (Intravenous Immunoglob...
Executive Summary
Azoth Analytics has released a research report titled "Global IgG Mediated Autoimmune Diseases Biologic Drugs Market (2024 Edition)" which provides a complete analysis of the Global IgG Mediated Autoimmune Diseases Biologic Drugs industry in terms of market segmentatio...
Executive Summary
Azoth Analytics has released a research report titled "Global Irritable Bowel Disease Market (2024 Edition)" which provides a complete analysis of the Global Irritable Bowel Disease industry in terms of market segmentation By Drug Class (Corticosteroids, JAK inhibitors...
The Intelligent Drug Delivery Technology Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape...
The Contract Drug Discovery Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ma...
The Automatic Sales Enablement System Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, m...
The Computer-assisted Drug Design Platform Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsca...
Executive Summary
Azoth Analytics has released a research report titled "Global Therapeutic Antibody Market (2023 Edition)" which provides a complete analysis of the Global Therapeutic Antibody industry in terms of market segmentation By Product Type (Monoclonal Antibody, Bispecific Ant...